Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 449.0 | 39 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 408.0 | 45 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 375.0 | 41 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 414.5 | 48 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 376.0 | 38 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 472.0 | 38 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 833.5 | 54 | |
N2759 | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 809.5 | 44 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 485.5 | 48 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 567.5 | 28 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 489.0 | 39 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | M-CSF | 412.0 | 30 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | M-CSF | 371.0 | 29 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | M-CSF | 390.0 | 41 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | M-CSF | 494.0 | 65 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | M-CSF | 523.0 | 59 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | M-CSF | 445.0 | 55 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | M-CSF | 412.0 | 55 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | M-CSF | 408.5 | 48 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | M-CSF | 392.5 | 38 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | M-CSF | 400.0 | 48 | ||||
RA1869 | 1 | M-CSF | 390.0 | 68 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | M-CSF | 595.0 | 50 | ||||
N2759 | 1 | M-CSF | 580.0 | 40 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | M-CSF | 477.0 | 39 |